Lentiviral vectors pseudotyped with engineered measles virus glycoproteins (hemagglutinin H and fusion F protein) have been retargeted to CD340/Her2/neu positive breast cancer cells [61], and to CD4 positive T lymphocytes [62]. The gene discussed is ERBB2; the disease is breast carcinoma.